TranscatTRNS
About: Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.
Employees: 1,104
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
60% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 40
48% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 21
7% more funds holding
Funds holding: 147 [Q2] → 157 (+10) [Q3]
3.06% more ownership
Funds ownership: 89.03% [Q2] → 92.09% (+3.06%) [Q3]
5% more capital invested
Capital invested by funds: $973M [Q2] → $1.02B (+$44.5M) [Q3]
44% less call options, than puts
Call options by funds: $48K | Put options by funds: $85K
50% less funds holding in top 10
Funds holding in top 10: 2 [Q2] → 1 (-1) [Q3]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Northland Capital Markets Ted Jackson 67% 1-year accuracy 2 / 3 met price target | 8%upside $110 | Market Perform Maintained | 30 Oct 2024 |
Oppenheimer Martin Yang 60% 1-year accuracy 9 / 15 met price target | 27%upside $130 | Outperform Reiterated | 30 Oct 2024 |
HC Wainwright & Co. Scott Buck 45% 1-year accuracy 41 / 92 met price target | 23%upside $126 | Buy Maintained | 30 Oct 2024 |
Craig-Hallum Greg Palm 73% 1-year accuracy 11 / 15 met price target | 10%upside $113 | Buy Maintained | 30 Oct 2024 |
HC Wainwright & Co. Scott Buck 45% 1-year accuracy 41 / 92 met price target | 52%upside $156 | Buy Reiterated | 29 Oct 2024 |
Financial journalist opinion
Based on 4 articles about TRNS published over the past 30 days
